Safety and Efficacy Study of New Drug for Cervical Dystonia

What we are studying

A new investigational botulinum toxin for injection in adults with isolated cervical dystonia.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
  • All Ethnicities
  • Ages 30 - 75

Eligibility Criteria

  • Meets diagnostic criteria for isolated cervical dystonia for at least 1 year prior to screening
  • At least moderate severity isolated cervical dystonia symptoms
  • With a baseline TWSTRS total score of at least 20 and at least 15 on the TWSTRS Severity subscale
  • Previous treatment with BOTOX for cervical dystonia
  • On a stable dose of medications used for focal dystonia treatment for at least 3 months prior to baseline and continuing through the end of the study.

What is involved

  • Questionnaires
  • Lab work
  • ECG. Cervical Dystonia Specific evaluations
  • Clinic visits
  • And telephone visits.


total of 650.00 if all visits are completed

Contact Information

Study Coordinator
Charlotte Miller, RN

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.